Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

CSL LIMITED

INVESTOR PRESENTATION - CSL LIMITED

ASX:CSL

CSL LIMITED

Health Care

CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. The operational businesses include CSL Behring and Seqirus. The Group operates predominantly in Australia, the USA, Germany, the United Kingdom and Switzerland.

Read more

Market Cap

133.96b

Price at Close

$294.43

4w avg. Volume

744.40k

4w avg. Turnover

$220.48m

Announcements
announcementt+2 movementdate
  • CSLs Annual R&D Investor Briefing 2020

    Periodic Reports

  • -2.30%

    19 Oct 2020

-2.30%

19 Oct 2020
  • Notice of Research & Development Investor Briefing

    Company Administration

  • -2.30%

    18 Oct 2020

-2.30%

18 Oct 2020
  • Appendix 3G

    Issued Capital

  • +0.68%

    16 Oct 2020

+0.68%

16 Oct 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • +0.68%

    16 Oct 2020

+0.68%

16 Oct 2020
  • Final Director's Interest Notice

    Shareholder Details

  • +0.68%

    16 Oct 2020

+0.68%

16 Oct 2020
  • Appendix 2A

    Issued Capital

  • -1.09%

    14 Oct 2020

-1.09%

14 Oct 2020
  • CSL 2020 AGM Poll Results

    Notice Of Meeting

  • -1.09%

    14 Oct 2020

-1.09%

14 Oct 2020
  • Chairman's Address to Shareholders

    Chairman's Address · Market sensitive

  • +0.93%

    13 Oct 2020

+0.93%

13 Oct 2020
  • Appendix 2A

    Issued Capital

  • +1.19%

    07 Oct 2020

+1.19%

07 Oct 2020
  • CSL Supply Agreement for UQ Vaccine with Commonwealth

    Progress Report · Market sensitive

  • +1.19%

    07 Oct 2020

+1.19%

07 Oct 2020
Market Data

Current Price

$294.43

52WK HIGH

$342.75

52WK LOW

$242.67

1YR RETURN

+14.62%

1YR RETURN VS. SECTOR

-5.27%

90 DAY RETURN

+7.28%

ASX RANK

1

/2,014

SECTOR RANK

1

/47

SHARES OUTSTANDING

454.97m
ASX:CSL

CSL LIMITED

Health Care

CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. The operational businesses include CSL Behring and Seqirus. The Group operates predominantly in Australia, the USA, Germany, the United Kingdom and Switzerland.

Read more

Market Cap

133.96b

Price at Close

$294.43

4w avg. Volume

744.40k

4w avg. Turnover

$220.48m

ASX:CSL is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.